Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes

Contrib Nephrol. 1991:88:271-2; discussion 273-5.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Anemia / drug therapy*
  • Blood Transfusion
  • Erythropoietin / therapeutic use*
  • Humans
  • Myelodysplastic Syndromes / drug therapy*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Erythropoietin